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Objective: Abnormal uterine contraction patterns were recently demonstrated in uterine strips from
pregnant women treated with Levothyroxine (T4). These abnormalities were correlated with an
increased risk of C-section delivery and associated surgical complications. To date, no study has inves-
tigated whether uterine contractility is modiﬁed by hypothyroidism or T4 treatment. Herein, we analyze
the physiological role of T4 on uterine contractions.
Study design: Female non-pregnant SpragueeDawley rats (N ¼ 22) were used and divided into four
groups: 1) control, 2) hypothyroidism, 3) hypothyroidism treated with low T4 doses (20 mg/kg/day) and
4) with high T4 doses (100 mg/kg/day). Hypothyroidism was induced by an iodine-deﬁcient diet. Iso-
metric tension measurements were performed in vitro on myometrium tissues in isolated organ baths.
Contractile activity parameters were quantiﬁed (amplitude, duration, frequency and area under the
curve) using pharmacological tools to assess their effect.
Results: Screening of thyroid function conﬁrmed a hypothyroid state for all rats under iodine-free diet to
which T4 was subsequently administered to counterbalance hypothyroidism. Results demonstrate that
hypothyroidism signiﬁcantly decreased contractile duration (17%) and increased contractile frequency
(þ26%), while high doses of T4 increased duration (þ200%) and decreased frequency (51%). These
results thus mimic the pattern of abnormal contractions previously observed in uterine tissue from T4-
treated hypothyroid pregnant women.
Conclusion: Our data suggest that changes in myometrial reactivity are induced by T4 treatment. Thus, in
conjunction with our previous observations on human myometrial strips, management of hypothy-
roidism should be improved to reduce the rate of C-sections in this group of patients.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Thyroid dysfunction has been associated with pregnancy com-
plications, including abortion, placental abruption, preterm birth
and fetal distress during labor [1e4]. Recently, our research group
observed dystonic in vitro uterine contractile patterns in uterine
strips from pregnant women under T4 treatment for hypothyroid-
ism during the entire course of their pregnancy. Uterine contrac-
tions of larger amplitude, longer duration and decreased frequency, New Orleans, LA, February
and Gynecology, Faculty of
ke, 3001, 12th Avenue North,
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e.ca (J.-C. Pasquier).
Inc. This is an open access article uwere observed in hypothyroid women treated with T4 compared to
contractile activity in controls [5]. These results hence raise the
issue of whether this modiﬁed contractile pattern is caused by
hypothyroidism or T4 treatment.
Thyroid disorders cause multiple uterine changes. At ﬁrst, hy-
pothyroidism inﬂuences uterine morphology. Inuwa et al. demon-
strated that under hypothyroid condition, uterine horns of rats
decrease in volume and weight, with a speciﬁcally notable decrease
in the muscle layer [6]. Moreover, modiﬁcations in contractility
have been established under thyroid dysfunction. T4 and T3 hor-
mones are known to modulate the expression of ionic channels,
pumps and regulatory contractile proteins. Kreuzberg et al.
demonstrated that in atria from patients presenting latent hyper-
thyroidism, expression levels of L-type Ca2þ channels were
increased more than threefold [7] which may potentially be
correlated with the increase in amplitude observed in myometrialnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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shown to inﬂuence calcium homeostasis and ﬂux responsible for
excitation and contractility, with T4 and T3 modulating its phar-
macological control and secretion [8]. Therefore, uterine respon-
siveness to various uterotonic agents is signiﬁcantlymodiﬁed under
thyroid disorders [9,10].
From a clinical standpoint, abnormal uterine contractions
resulting in protracted labor can lead to C-section and increased
maternal morbidity associated with surgical risk [11]. An epide-
miological review of two cohort studies revealed a two-fold higher
rate in C-section deliveries in pregnant women with hypothyroid-
ism [12,13]. Interestingly, Sahu et al. also demonstrated a higher
C-section rate in the hyperthyroidism group [13]. A better under-
standing of the origin of these abnormal patterns is thus needed in
order to decrease the alarming rate of cesarean sections in this
particular population.
The aim of the present study was to analyze whether contractile
activity is modiﬁed by hypothyroidism or T4 treatments as assessed
by isometric tensionmeasurement methods. The speciﬁc objectives
were to conﬁrm the hypothyroid status induced by an iodine
deﬁciency diet and to quantify uterine contractile parameters and
uterine reactivity to pharmaceutical agents under various thyroid
states in timed non-pregnant rats.Figure 1. Screening of thyroid function to conﬁrm hypothyroid status. ELISAwere performed
type 1 (DIO1) in uterine tissues obtained from control, hypothyroid and levothyroxine (T4)-tr
5 identical experiments. *p < 0.05.Materials and methods
Animals
SpragueeDawley female rats (N ¼ 22) were obtained from
Charles River Laboratories (Saint-Constant, QC, Canada). The
experimental protocol (No 297-12) was approved by the Institu-
tional Animal Research Ethics Review Board. The study conformed
to the animal protection laws of the Animal Care and Use Com-
mittee of the Université de Sherbrooke (Sherbrooke, Québec,
Canada) and to current Canadian Council for Animal Care (CCAC)
guidelines. Non-pregnant rats were divided into four groups: 1)
control, 2) hypothyroidism, 3) hypothyroidism treated with low
doses of Levothyroxine (T4) (20 mg/kg/day) and 4) with high doses
of T4 (100 mg/kg/day). Control rats (group 1) were fed with
standard diet (TD.120461, Harlan laboratories, Madison, WI) while
the intervention rats were fed with iodine-free diet (TD.120460,
Harlan laboratories, Madison, WI) for 12 weeks to induce hypo-
thyroidism (groups 2e4) which was continued for four more
weeks to allow screening of hypothyroid status and T4-treatment.
Food and water (iodine-free diet) were available ad libitum. The
hypothyroid group treated with low (group 3) or high doses of T4
(group 4) were injected intraperitoneally every 24 h withto measure T3 (A) and T4 (B) concentrations (N ¼ 6/group). (C) Detection of Deiodinase
eated non-pregnant rats. (D) Western blot quantiﬁcation. This ﬁgure is representative of
Figure 2. Spontaneous in vitro uterine contractile activity in control, iodine-deﬁcient
and T4-treated non-pregnant rat groups. Typical recordings in control (A), under
iodine deﬁciency (B) and in 20 mg/kg (C) and 100 mg/kg (D) levothyroxine (T4)-treated
rats under iodine deﬁciency conditions.
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described by Medeiros [9]. Blood samples were collected for
thyroid function screening at week 12 and 16 following the
initiation of either the control or iodine-free diet. Hysterectomy
was performed under general anesthesia (isoﬂurane 2%) at the
end of the treatment and the two uterine horns were placed in
physiological Krebs’ solution until isometric tension measure-
ments within no more than 1 h.
Tissue preparation and isometric tension measurements
Once collected, all uterine horns were dissected in rings
and either placed in Krebs physiological solution at pH 7.4
containing the following: 118 mM sodium chloride, 25 mM so-
dium bicarbonate, 11.1 mM glucose, 4.7 mM potassium chloride,
2.5 mM calcium chloride, 1.2 mM magnesium sulfate and 1.2 mM
potassium phosphate (SigmaeAldrich, St. Louis, MO) or snap
frozen (80 C) for biochemical analysis. The myometrial rings
were mounted in organ chambers (Radnoti Glass Tech., Monrovia,
CA) between 2 inox wire stirrups for isometric tension recording.
For each tissue, 1 stirrup was ﬁxed to the bottom of the chamber,
and the other was connected to an isometric force transducer
coupled to Polyview software (Grass-Astro-Med Inc, West War-
wick, RI). The organ chambers contained 7 ml of Krebs solution
maintained at 37 C and continuously bubbled with a mixture of
95% oxygen/5% carbon dioxide (pH 7.40) as previously described
[14]. After a 1 h equilibration period, spontaneous contractile
activity was recorded after which tested agents were sequentially
added.
Biochemical techniques
ELISA assays were performed using a standard rat Thyroxine
(T4) and T3 ELISA kit according to the manufacturer’s protocol
(Neobiolab, Cambridge, MA). Western blot analysis was performed
exactly as previously described [5].
Drug and chemicals
T4 was dissolved in saline solution (Medical grade; Hospira, CA)
at pH 8 and stored at 4 C for a maximal period of 1 week. The
solution was sterilized before animal administration. All chemicals
were purchased from Sigma (St-Louis, MO). Antibodies including
rabbit antiserum raised against DIO1, OXTR and b-actin proteins
were purchased from Abcam (Cambridge, MA).
Data and statistical analysis
Contractile activities were quantiﬁed by calculating the ampli-
tude, the duration, the frequency and the area under the curve over
10-min periods using Sigma Plot 12.0 (SPSS-Science, Chicago, IL).
The effects of the pharmacological agent, methacholine (Sigmae
Aldrich, St. Louis, MO), were corrected for the effect of the vehicle
(aqueous solution). Results are expressed as means  S.E.M. Sta-
tistical analyses were performed using Student’s t test with p< 0.05
considered as statistically signiﬁcant.
Results
Effects of iodine-free diet on plasma T3 and T4 concentrations
Fig. 1A and B displays the plasma levels of T3 and T4 thyroid
hormones in the four different groups, quantiﬁed by ELISA. In rats
fed 12 weeks with the iodine-free diet, a signiﬁcant decrease in
the levels of both T3 and T4 was observed when compared to thecontrol group fed with standard diet (p < 0.001; p ¼ 0.009).
In the group treated with low doses of T4, an increase in T4 levels
was observed (p ¼ 0.02) while T3 levels remained virtually similar
to the control group (p ¼ 0.19). Rats treated with high doses of T4
displayed a signiﬁcant increase in both T3 and T4 circulating
concentrations compared to the non-treated hypothyroid group
(p < 0.001 and p ¼ 0.004, respectively) and a signiﬁcant increase
in T4 levels when compared to the control values (p ¼ 0.03).Detection of deiodinase type 1 in uterine tissue
The deiodinase type 1 (DIO1) is responsible for the conversion of
T4 into its active T3 form. In keeping with a previous study which
showed the presence of this isoform in uterine tissues [5], DIO1
protein was quantiﬁed by Western blotting. Using a primary anti-
body raised against DIO1 (Santa Cruz, CA), an immunoreactive band
of 78 kDa was consistently detected in all tested cytosolic samples
while a 42 kDa band was detected using b-actin antibody (Fig. 1C).
According to mean immunostaining levels, this 78 kDa band was
predominantly detected in themyometrium from the group treated
with high doses of T4 (Fig. 1D; p ¼ 0.03).
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Fig. 2 displays typical recordings of spontaneous contractile
activities. The typical pattern obtainedwith uterine tissues from the
control group showed rhythmic activities with a contraction phase
followed by a rapid relaxation phase (Fig. 2A). In the hypothyroid
group, this relaxation ability was partially lost, which translated
into a higher frequency and a change in apparent basal tone
(Fig. 2B). In the group treated with low doses of T4, the contraction
patterns recovered their rhythmicity, similar to that recorded in the
control group (Fig. 2C). In contrast, the contractile patterns of the
group treated with high doses of T4 displayed abnormal but
consistent contractile activity with a major increase in duration and
a decrease in frequency (Fig. 2D).
Analysis of contractile parameters
The mean maximal amplitude of contractions was 0.89  0.08 g,
0.90  0.06 g, 0.99  0.12 g and 0.66  0.08 g for groups 1 to 4,
respectively (Fig. 3A). No signiﬁcant changeswere observed between
groups 2 to 4,when compared to the control group (p¼ 0.74; p¼ 0.42
and p¼ 0.10, respectively). However, the time to peak of contractions
was signiﬁcantly increased in the group treatedwith high doses of T4
(49.7  5.8 s) compared to the control group (27.8  1.2 s) while the
time to peak was reduced in the hypothyroidism group (24.0 1.1 s)Figure 3. Modiﬁcations in uterine contractile parameters in control, iodine-deﬁcient and T4
relaxation (C) and frequency (D) were quantiﬁed in the four experimental groups (n ¼ 36/compared to the control group (Fig. 3B; p< 0.05). The same increase
was also observed for duration to 90% of relaxation (Fig. 3C). In the
control group, ameanduration of 48.31.5 swas recordedwhile the
hypothyroid state induced a decrease in duration (40.6  2.1 s).
Conversely, a dose-dependent increase in the durationwas recorded
in the groups treated with low (64.6  12.8 s) and high doses of T4
(148.8  24.4 s) compared to the control group. Finally, contractile
frequency was increased in the hypothyroid group while a net
decrease was observed under high doses of T4 (Fig. 3D). The fre-
quency determined in the low T4 dose-treated group remained
similar than to that observed in the control group.
Uterine reactivity
The expression levels of the oxytocin receptor were determined
in order to assess uterine reactivity between the four groups. As can
be seen in Fig. 4A, using a speciﬁc antibody, the oxytocin receptor
was detected in all protein fractions. However, semi-quantitative
analysis (Fig. 4B) revealed a higher expression level for the preg-
nant group, used as a positive control, compared to all four non-
pregnant groups (p < 0.001). Oxytocin concentration response
curves were also performed, although are not shown due to the
small reactivity of non-pregnant uterine tissues compared to
pregnant uterine tissues. There were no differences detected be-
tween the 4 groups following analysis of the area under the curve.-treated non-pregnant rat groups. The amplitude (A), time to peak (B), duration to 90%
group). *p < 0.05, ***p < 0.001.
Figure 4. Oxytocin receptor detection. (A) Western blot analysis conﬁrmed a lower
expression of the receptor in non-pregnant rats compared with pregnant rats. The
obtained membrane fractions from pregnant rats were used as a positive control. (B)
Quantitative analysis of the OXTR/b-actin ratio (n ¼ 5). ***p < 0.001.
Figure 5. Non-pregnant rat uterine responsiveness to methacholine. Cumulative
concentration response curves to methacholine in control and hypothyroid condition
in the absence or presence of low or high doses of T4 (n ¼ 6e8/group). *p < 0.05 when
compared to the control group.
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(CCRC) to methacholine (MCh) in order to assess the effect of low
and high doses of T4 treatment on myometrial responsiveness to a
speciﬁc uterotonic compound. A greater than two-fold increase was
recorded for MCh in the hypothyroid group compared to the reac-
tivity of the control group (p ¼ 0.002). Following T4 treatments (20
and 100 mg/kg/day, respectively), a dose-dependent reversing effect
was observed. These results suggest that thyroid status modulates
both uterine contractility and pharmacological reactivity.
Discussion
This is the ﬁrst in vitro study demonstrating the effect of T4
treatments on uterine contraction patterns during a hypothyroid
state. In contrast to that recorded in the hypothyroid group, larger
contractions with a decreased frequency of phasic contractions
were observed in the group treated with 100 mg/kg/day of T4. This
speciﬁc observation corroborates the ﬁrst evidence showing an
abnormal in vitro uterine contraction pattern in women with hy-
pothyroidism and treated with T4 [5].Animal model
While the present analysis succeeds in establishing whether this
particular abnormal pattern is caused by hypothyroidism or its
treatment, some limitations remain. One of the limitations of the
present model is the absence of gestational status. It is well known
that a hypothyroid condition increases infertility and being able to
conceive under a hypothyroid state constitutes a genuine achieve-
ment [2,15]. However, a pseudo-induction of decidualization is
nonetheless achievable [16], although the latter has not been tested
for its effects on uterine contractility. Despite this absence of a
pseudo- or gestational status, the purpose of the study was to
analyze the effect of hypothyroidism and its treatment on uterine
contractility which was easily achieved in our non-pregnant model.
Moreover, a study comparing gravid and non-gravid rats reported
no obvious difference in myosin and functional properties of uter-
ine tissues, i.e. in vitro uterine contractility [17]. Our research group
has also already demonstrated that spontaneous activities were
obtained in both types of myometrial tissues [5]. For these reasons,
this study was conducted using non-pregnant rat myometrium and
this current animal model easily provides a better understanding of
the speciﬁc effect of thyroid disorders on myometrial contractility
in vitro.
Hypothyroidism induced by a 12-week iodine-deﬁcient diet was
conﬁrmed, as evidenced by a substantial decrease of over 40% in T3
and T4 circulating levels compared to the control group (61%
and 40%, respectively). Using methimazole, Parija et al. also ach-
ieved similar observations, with an approximately 50% decrease in
both T3 and T4 plasma levels [18]. Since DIO1 is responsible for the
conversion of T4 in T3, it was therefore important to ensure that the
treated rats were able to generate the active metabolite T3. Results
indeed conﬁrmed the presence of the enzyme in all tested groups of
rats. Moreover, an enhanced immunoreactive band was quantiﬁed
in the high dose T4-treated group, likely induced as the result of the
high level of circulating T4, synthesis of T3 and activation of nuclear
thyroid hormone receptors.Effect of thyroid disorders on uterine contraction patterns
Altogether, the data collected from non-pregnant rats show
that thyroid disorders induced a modiﬁcation in uterine con-
tractile patterns. A dose-dependent effect was indeed observed
S. Corriveau et al. / Journal of Clinical & Translational Endocrinology 2 (2015) 144e149 149on the measured contractile parameters in all three intervention
groups. Both hypothyroidism and excess T4 demonstrated
distinctive abnormal contractile modiﬁcations. On the one hand,
results demonstrate that hypothyroidism decreased both time to
peak and duration to 90% relaxation, while increasing the fre-
quency of contractile activity. Parija et al. also demonstrated an
increased frequency of spontaneous rhythmic contractions in 18-
day pregnant rat uterus [19]. In contrast, when the hypothyroid
rats were treated with high doses of T4 (100 mg/kg/day), a sub-
stantial increase in the duration of phasic contractions along
with a decrease in frequency were observed. Of note, in the
hypothyroid rats group treated with low T4 doses (20 mg/kg/day),
analysis of the contractile pattern revealed a return to baseline
values. These results could be extended to the modiﬁcations
observed on the in vitro contractile activity in pregnant women
presenting hypothyroidism under T4-treatment, which displayed
an increased duration and a decreased frequency [5]. Our data
hence suggest that the abnormal changes in myometrial reac-
tivity of the uterine tissues are likely related to T4
supplementation.
This effect of T4 treatment could be explained by the action of
thyroid hormones on ionic channels. An elevation in calcium
channel mRNA expression has been demonstrated in atrial cells
under hyperthyroid conditions [7]. As a result, the expression of
Kþ channels, SERCA and ionic pumps are modiﬁed. Moreover,
uterine activity after acute muscarinic agonist treatment (con-
centration increments of methacholine) were shown herein to be
enhanced in hypothyroid condition. Female rats treated with high
doses of T4 furthermore showed a decreased reactivity to this
uterotonic agent. These results are thus consistent with a previous
report [9].
In summary, the present study establishes that abnormal uterine
contraction patterns can be observed under hypothyroidism with
and without T4 treatments. These ﬁndings putatively explain the
atypical contraction pattern observed in vitro in pregnant women
treated with T4 to counterbalance a hypothyroid condition. Our
current observations, obtained in an in vivo rat model, lead us to
propose the translational hypothesis that a better management of
this group of pregnant women may help avoid abnormal labor
patterns which could cause a higher rate of C-sections in this
particular population. A speciﬁc intervention aimed at improving
the adjustment of T4 administration at the end of pregnancy would
help in solving this issue.Conﬂicts of interest
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